Oncology Corporate Profile
EpicentRx, a clinical stage biotechnology company, is at the forefront of the rapidly emerging field of epigenetics and has the potential to change the face of medicine. With a focus on the epicenter of life science innovation and forward-thinking leadership, EpicentRx embodies a “radical” new approach to discover and develop improved therapeutic options from non-traditional sources for unmet medical needs.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|RRx-001||free radical stimulant||Colorectal cancer||II|
|RRx-001||free radical stimulant||Non Small Cell Lung Cancer (NSCLC)||I|
|RRx-001||free radical stimulant||Non-Hodgkin's Lymphoma (NHL)||I|
|RRx-001||free radical stimulant||Small Cell Lung Cancer (SCLC)||I|